Original languageEnglish
Article numberDOI: 10.31083/j.jmcm.2018.01.005
Pages (from-to)37-46
Number of pages10
JournalJournal of Molecular and Clinical Medicine
Volume1
Issue number1
Publication statusPublished - 18 Jan 2018

Cite this

@article{e5f0b6f0e24348518b8d9f01b7bc3e2c,
title = "Enhanced Dendritic Cell Development Through Long-Term Proteasome Inhibition",
keywords = "bortezomib, proteasome inhibitor, dendritic cell, Immunotherapy, Langerhans Cells",
author = "{van de Ven}, Rieneke and Verbrugge, {Sue Ellen} and Marjon Al and Henk Dekker and HMW Verheul and Anderl, {Janet L.} and Chan, {Elana T} and BAC Dijkmans and WF Lems and RJ Scheper and G Jansen and {de Gruijl}, TD",
year = "2018",
month = "1",
day = "18",
language = "English",
volume = "1",
pages = "37--46",
journal = "Journal of Molecular and Clinical Medicine",
number = "1",

}

Enhanced Dendritic Cell Development Through Long-Term Proteasome Inhibition. / van de Ven, Rieneke; Verbrugge, Sue Ellen; Al, Marjon; Dekker, Henk; Verheul, HMW; Anderl, Janet L.; Chan, Elana T ; Dijkmans, BAC; Lems, WF; Scheper, RJ; Jansen, G; de Gruijl, TD.

In: Journal of Molecular and Clinical Medicine, Vol. 1, No. 1, DOI: 10.31083/j.jmcm.2018.01.005, 18.01.2018, p. 37-46.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Enhanced Dendritic Cell Development Through Long-Term Proteasome Inhibition

AU - van de Ven, Rieneke

AU - Verbrugge, Sue Ellen

AU - Al, Marjon

AU - Dekker, Henk

AU - Verheul, HMW

AU - Anderl, Janet L.

AU - Chan, Elana T

AU - Dijkmans, BAC

AU - Lems, WF

AU - Scheper, RJ

AU - Jansen, G

AU - de Gruijl, TD

PY - 2018/1/18

Y1 - 2018/1/18

KW - bortezomib

KW - proteasome inhibitor

KW - dendritic cell

KW - Immunotherapy

KW - Langerhans Cells

M3 - Article

VL - 1

SP - 37

EP - 46

JO - Journal of Molecular and Clinical Medicine

JF - Journal of Molecular and Clinical Medicine

IS - 1

M1 - DOI: 10.31083/j.jmcm.2018.01.005

ER -